Submitted by dcc on Thu, 2020-10-01 09:20 Study Title: Older Non-Small Cell Lung Cancer Patients (>/= 70 Years of Age) Treated with First-Line MK-3475 (Pembrolizumab) +/- Chemotherapy (Oncologist's/Patient's Choice)CIRB: Cancer Prevention and Control CIRBLead Group: AllianceStatus: ActiveReview Status: Available to Open
